Earnings per share (EPS) of -$0.23, missing the expected $0.10.Revenue of $314.8 million, surpassing the estimated $308 million.Strong financial health indicated by a current ratio of 3.83.Confluent, Inc. (NASDAQ:CFLT) is a prominent player in the data streaming industry. The company specializes in providing a platform that enables real-time data processing and analytics, crucial for businesses leveraging big data and artificial intelligence. Confluent's main competitors include companies like Apache Kafka ...

For the quarter ended December 2025, Confluent (CFLT) reported revenue of $314.82 million, up 20.5% over the same period last year. EPS came in at $0.12, compared to $0.09 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $307.29 million, representing a surprise of +2.45%. The company delivered an EPS surprise of +22.08%, with the consensus EPS estimate being $0.10.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and h ...

数据流平台领军者Confluent(CFLT.US)于2月11日美股盘后正式公布了其 2025财年第四季度及全年财务 报告，这也是该公司在被科技巨头IBM(IBM.US)彻底私有化之前，作为独立上市公司的最后一份年度成 绩单。报告显示，Confluent 在核心云业务及盈利能力提升方面表现远超市场预期。截至2025年12月31 日的第四财季，公司总营收攀升至 3.148 亿美元，同比增长21%。其中，旗舰产品 Confluent Cloud 表现 尤为强劲，单季贡献收入 1.69 亿美元，同比增幅达 23%。在盈利指标方面，Confluent 成功实现了利润 率的跨越式增长。第四季度 Non-GAAP 每股收益达到 0.12 美元，显著高于分析师普遍预期的 0.10 美 元。 随着数据流技术从"可选"转变为 AI 时代的"必备"基础设施，并入 IBM 版图后的 Confluent 将如何与 watsonx 等平台深度整合，已成为业界关注的下一个焦点。 从全年维度看，公司 2025 财年总营收达到 11.67 亿美元，订阅收入达 11.2 亿美元，同比增长 21%。尤 为引人注目的是，公司的现金流状况得到了根本 ...

此次财报的发布正处于 IBM 110亿美元收购案的关键节点。2025年12月，IBM 宣布以每股 31 美元的全 现金方式收购 Confluent，旨在强化其在生成式 AI 与代理型 AI (Agentic AI) 领域的数据底座能力。 随着数据流技术从"可选"转变为 AI 时代的"必备"基础设施，并入 IBM 版图后的 Confluent 将如何与 watsonx 等平台深度整合，已成为业界关注的下一个焦点。 智通财经APP获悉，数据流平台领军者Confluent(CFLT.US)于2月11日美股盘后正式公布了其 2025财年 第四季度及全年财务报告，这也是该公司在被科技巨头IBM(IBM.US)彻底私有化之前，作为独立上市公 司的最后一份年度成绩单。报告显示，Confluent 在核心云业务及盈利能力提升方面表现远超市场预 期。截至2025年12月31日的第四财季，公司总营收攀升至 3.148 亿美元，同比增长21%。其中，旗舰产 品 Confluent Cloud 表现尤为强劲，单季贡献收入 1.69 亿美元，同比增幅达 23%。在盈利指标方面， Confluent 成功实现了利润率的跨越式增长。第四季 ...

Confluent (CFLT) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +22.08%. A quarter ago, it was expected that this data infrastructure software maker would post earnings of $0.1 per share when it actually produced earnings of $0.13, delivering a surprise of +30%.Over the last four quar ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _______________________________________________________________________________________________ FORM 10-K _______________________________________________________________________________________________ (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANG ...

Confluent Announces Fourth Quarter and Fiscal Year 2025 Financial Results MOUNTAIN VIEW, Calif. -- February 11, 2026 -- Confluent, Inc. (NASDAQ: CFLT), the data streaming pioneer, today announced financial results for its fourth quarter and fiscal year 2025, ended December 31, 2025. "Confluent delivered a strong fourth quarter to close the year, including 23% year over year growth in Confluent Cloud," said Jay Kreps, co-founder and CEO, Confluent. "Our AI product advancements and continued innovation across ...

We came across a bullish thesis on Confluent, Inc. on Outperforming the Market’s Substack by Simple Investing. In this article, we will summarize the bulls’ thesis on CFLT. Confluent, Inc.'s share was trading at $30.53 as of January 28th. CFLT’s forward P/E was 62.50 according to Yahoo Finance. Charts Confluent, Inc. operates a data streaming platform in the United States and internationally. CFLT demonstrated resilience in 3Q25, highlighting that its focus on fundamentals is beginning to pay off. The c ...

Core Insights - Confluent Medical Technologies has launched Filmcast Select™, a materials customization program for polymer tubing that allows customers to select key performance attributes of Filmcast PTFE and polyimide tubing [1][2] Group 1: Product Offering - The standard Filmcast polymer tubing process lacks customization, which is increasingly necessary as medical devices become smaller and more complex; Filmcast Select™ addresses this need by allowing OEMs to choose tubing based on critical characteristics such as flexibility, strength, durability, surface finish, regulatory compliance, and optical clarity [2][3] - Filmcast Select™ includes multiple polyimide tubing options, such as standard polyimide, REACH-compliant glossy and matte polyimide, and Ultra Polyimide, offering benefits like high transparency, reduced friction, and nearly double the tensile strength of standard polyimide for thin-wall designs [3][4] - The program also features various Filmcast PTFE options, including FlexaCast™ for increased flexibility, DuraCast™ for enhanced abrasion resistance, and UltraCast™ for higher tensile strength in demanding applications [4] Group 2: Customer Collaboration - Confluent Medical can collaborate with customers on preferred PTFE dispersions, enabling OEMs to utilize existing biocompatibility data and shorten development time for new or next-generation devices [4] Group 3: Company Background - Confluent Medical specializes in the design, development, and large-scale manufacturing of interventional catheter-based devices and implants, with expertise in Nitinol materials, balloon and complex catheters, high-precision polymer tubing, and implantable textiles [5] - The company operates facilities in multiple locations, including California, Rhode Island, Maine, Texas, Tennessee, Costa Rica, and India, and has established a strong reputation in the medical device community through innovative materials science and engineering [5]

Group 1 - Top Wall Street analysts have revised their outlook on several prominent companies, indicating a shift in market sentiment [1] - The article suggests that investors should consider the stock of TTD, highlighting the opinions of analysts regarding its potential [1]